Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Biotech (Basel (Switzerland))|July 13, 2022
Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through ChromatographyElad Lerer, Ziv Oren, Yaron Kafri, et al.
Journal of Virological Methods|February 26, 2022
SARS-CoV-2 spike antigen quantification by targeted mass spectrometry of a virus-based vaccineOsnat Rosen, Avital Jayson, Eyal Dor, et al.
Frontiers in Immunology|September 5, 2022
Centaur antibodies: Engineered chimeric equine-human recombinant antibodiesRonit Rosenfeld, Ron Alcalay, Anat Zvi, et al.
Cancers|June 24, 2022
Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In VivoShiri Davidi, Sara Jacobovitch, Anna Shteingauz, et al.
Cancers|February 25, 2023
Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, et al.
Frontiers in Oncology|July 12, 2024
Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistanceYani Berckmans, Hila M Ene, Kerem Ben-Meir, et al.
Frontiers in Oncology|March 25, 2026
Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cellsHila Fishman, Hila M Ene, Einav Zeevi, et al.
Vaccine|November 10, 2021
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidateArik Makovitzki, Elad Lerer, Yaron Kafri, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2021
Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical modelsHelena Mumblat, Antonia Martinez-Conde, Ori Braten, et al.
Frontiers in Microbiology|December 14, 2023
Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical studyAvraham Abutbul, Helena Mumblat, Yaara Porat, et al.
Pageof 4